An FDA-approved drug used to treat multiple myeloma and lymphoma also shrank tumors in non-small cell lung cancer with KRAS ...
GSK (GSK) reported a study showed its drug belantamab mafodotin was able to reduce the risk of death by 42% in certain ...
In 2022, the U.S. Congress enacted the Inflation Reduction Act (IRA), a landmark piece of legislation aimed at addressing various national priorities, including the reduction of prescription drug ...
That is the finding of an observational study reported at the American Society of Haematology (ASH) congress, which focused on allogeneic or donor HSCTs used as a potentially curative treatment for ...
AEYE Health , the leader in artificial intelligence-based diagnostics for retinal imaging, and UMass Memorial Health (UMMH), ...
Collaboration to evaluate monoclonal antibody as first-in-class treatment in this settingREDWOOD CITY, Calif. and HOUSTON, ...
UnitedHealth Group Incorporated faces risks from public pressure and policy changes, making it a questionable investment ...
From powerful, data-driven insights and strategic consultancy support to agenda-setting events and hiring solutions, our products and services enable everyone in higher education to make smarter, more ...
Immutep (ASX:IMM) has announced the initiation of its TACTI-004 Phase III clinical trial, which aims to evaluate the efficacy ...
Perpetual (ASX:PPT) has provided an update on its proposed scheme of arrangement with KKR, revealing that tax complications ...
The U.S. dermal fillers market has become one of the most rapidly growing sectors within the broader cosmetic and ...
Covering Saudi Arabia’s markets, the report includes: It encompasses a robust vendor analysis tailored to assist clients in enhancing their market positioning. Specifically, the report furnishes a ...